Antiplatelet agents and anticoagulants increased the bleeding risk of bedside percutaneous dilational tracheostomy in critically ill patients.

CONCLUSION: Our study demonstrated that it was feasible for pulmonologists to perform bedside PDT in critically ill patients. However, antiplatelet agents and anticoagulants use increased the risk of bleeding in PDT patients. PMID: 31685407 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31685407?dopt=Abstract

Source: J Formos Med Assoc - November 1, 2019 Category: General Medicine Authors: Huang YH, Tseng CH, Chan MC, Lee BJ, Lin CH, Chang GC Tags: J Formos Med Assoc Source Type: research